Song In-Kyung, Lee Ji-Hyun, Jung SungAe, Kim Jin-Tae, Kim Hee-Soo
Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea.
Indian J Pharmacol. 2015 Jul-Aug;47(4):360-4. doi: 10.4103/0253-7613.161251.
Although targeting the effect site concentration may offer advantages over the traditional forms of administering intravenous anesthetics, it is not applicable for sufentanil in children because its plasma effect site equilibration rate constant (ke0) is not known yet. We estimated ke0 of sufentanil in children using the time to peak effect (t peak) method.
Under general anesthesia, sufentanil t peak was measured after administration of a submaximal bolus dose by means of the decrease in heart rate, blood pressure and calculated approximate entropy (ApEn) of electroencephalogram in 105 children (age range: 3-11 years). ke0 was estimated using t peak and known sufentanil pharmacokinetic parameters in normal children.
The mean t peaks were measured as 44 ± 22 s and 227 ± 91 s by heart rate and by mean blood pressure respectively. The estimated ke0 were 5.16/min and 0.49/min by heart rate and blood pressure respectively. t peak could not be measured using the ApEn, thus ke0 could not be calculated by ApEn in children.
Shorter measured sufentanil t peak by heart rate compared to blood pressure indicate that the heart rate decrease faster than decreasing of blood pressure. Moreover, the calculated sufentanil ke0 in children depends on the pharmacodynamics parameters.
尽管靶向效应室浓度相较于传统静脉麻醉药给药方式可能具有优势,但由于儿童舒芬太尼的血浆-效应室平衡速率常数(ke0)尚不清楚,因此该方法不适用于儿童舒芬太尼。我们采用效应峰值时间(tpeak)法估算了儿童舒芬太尼的ke0。
在全身麻醉下,通过测量105名儿童(年龄范围:3至11岁)心率、血压的下降以及计算脑电图的近似熵(ApEn),在给予次最大推注剂量后测定舒芬太尼的tpeak。使用tpeak以及正常儿童已知的舒芬太尼药代动力学参数估算ke0。
通过心率和平均血压测得的平均tpeak分别为44±22秒和227±91秒。通过心率和血压估算的ke0分别为5.16/分钟和0.49/分钟。无法使用ApEn测量tpeak,因此无法通过ApEn计算儿童的ke0。
与血压相比,通过心率测得的舒芬太尼tpeak更短,这表明心率下降比血压下降更快。此外,儿童舒芬太尼ke0的计算取决于药效学参数。